Response to A critique of the European Commission Document, “State of the Art Assessment of Endocrine Disrupters” by Rhomberg and colleagues – letter to the editor

Andreas KortenkampInstitute for the Environment, Brunel University, London, UK

Olwenn MartinInstitute for the Environment, Brunel University, London, UK

Richard EvansInstitute for the Environment, Brunel University, London, UK

Frances OrtonInstitute for the Environment, Brunel University, London, UK

Rebecca McKinlayInstitute for the Environment, Brunel University, London, UK

Erika RosivatzImperial College, London, UK

Michael FaustFaust and Backhaus Environmental Consulting, Bremen, Germany

show all

References

Cortes D, Kjellberg EM, Breddam M, Thorup J. (2008). The true incidence of cryptorchidism in Denmark. J Urol 179:314–318.
PubMed Web of Science ®Google Scholar
Kortenkamp A, Martin O, Faust M, Evans R, McKinlay R, Orton F, Rosivatz E. (2011). State of the art assessment of endocrine disrupters. Final report. Available at: http://ec.europa.eu/environment/endocrine/documents/4_SOTA%20EDC%20Final%20Report%20V3%206%20Feb%2012.pdf. Accessed on 12 March 2012.
Google Scholar
Thorup J, McLachlan R, Cortes D, Nation TR, Balic A, Southwell BR, Hutson JM. (2010). What is new in cryptorchidism and hypospadias – a critical review on the testicular dysgenesis hypothesis. J Pediatr Surg 45:2074–2086.
PubMed Web of Science ®Google Scholar
Rhomberg LR, Goodman JE, Foster WG, Borgert CI, Van Der Kraak G. (2012). A critique of the European Commission document “State of the art assessment of endocrine disrupters”. Crit Rev Toxicol early online 1–9.
Web of Science ®Google Scholar
WHO (World Health Organization)/International Programme on Chemical Safety (IPCS). (2002). Global assessment of the state of-the-science of endocrine disruptors. Available at: http://www.who.int/ipcs/publications/new_issues/endocrine_disruptors/en/. Accessed on 4 October 2002.
Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Response to A critique of the European Commission Document, “State of the Art Assessment of Endocrine Disrupters” by Rhomberg and colleagues – letter to the editor

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Response to A critique of the European Commission Document, “State of the Art Assessment of Endocrine Disrupters” by Rhomberg and colleagues – letter to the editor

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date